Delisted
Stopped trading. Fund positions aren't valued until we confirm what happened.
Reata Pharmaceuticals Inc
RETA·75615P103·US·Common Stock
RETA (Reata Pharmaceuticals Inc) is held by 0 institutional investors as of Q3 2023.
0
Holders
$0
Total Value
0%
Consensus
13F: Insider & Congress: Updated regularly
No verdict yet — fewer than 2 funds hold RETA.
Top Holders
Checking access…
| Action | ||||||
|---|---|---|---|---|---|---|
Exited | 0(-100.0%) | $75,043 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $3.1M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $827,609 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $9.7M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $353,699 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $1M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $1.1M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $8.6M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $611,760 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $2.7M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $4.9M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $21.6M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $672,936 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $30.2M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $619,407 | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $34.7M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $8.6M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $1M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $12.9M | 0.0% | — | 0 | |
Exited | 0(-100.0%) | $591,161 | 0.0% | — | 0 |
Showing 1-20 of 103
1 / 6
RETAReata Pharmaceuticals IncContinue exploring
Similar stocks
FISVFiserv Inc334 holders · $21.5B
SPYSPDR S&P 500 ETF Trust294 holders · $348.2B
IVViShares Core S&P 500 ETF262 holders · $566.9B
QQQInvesco QQQ Trust Series 1246 holders · $125.8B
VOOVANGUARD S&P500 INDEX ETF245 holders · $264.7B
IWMiShares Russell 2000 ETF242 holders · $68.1B
GLDSPDR GOLD TRUST GOLD SHS237 holders · $34.1B
XLFFinancial Select Sector SPDR Fund224 holders · $31.5B
XLEEnergy Select Sector SPDR Fund223 holders · $17.3B
EFAiShares MSCI EAFE ETF221 holders · $47.1B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer